ZTS
Zoetis Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$79.59
+0.26%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$78.85
From 52W high−46.05%
Volume2.82M
Market cap$32.89B
P/E (TTM)13.1x
P/S (TTM)3.5x
Div yield1.33%
Key dataOct 19, 2026
Open
$78.85
From 52W high
−46.05%
Volume
2.82M
Market cap
$32.89B
ValuationView details →
P/E (Fwd)
12.7x
EV/EBITDA
10.1x
P/E (TTM)
13.1x
RSI (14)
69.8
MomentumView details →
1D Return
+0.26%
YTD Return
−36.74%
SummaryUpdated Jun 1, 2026
Zoetis Inc. (NYSE:ZTS) is the world's largest animal health company, founded in 1952 and spun off from Pfizer in 2013 through an initial public offering. Headquartered in Parsippany, New Jersey, the company has evolved from a pharmaceutical division into an independent leader in veterinary medicine, serving both companion animals and livestock across global markets. With operations spanning the United States and international markets, Zoetis has established itself as a dominant force in animal healthcare through decades of scientific innovation and strategic market expansion.
Similar companies
Latest newsMore news →
ROY MORGAN RESEARCH LTD's annual farmer survey named Zoetis Inc., Bendigo and Adelaide Bank, GRAINCORP LIMITED, Meat & LIvestock Australia, and Nutrien Ltd. as repeat winners in their respective agribusiness brand categories.5d agoZoetis appointed Iris Knobloch as a director, effective December 1, 2026.7d ago